The GRID-HAMD: standardization of the Hamilton Depression Rating Scale

International Clinical Psychopharmacology
Janet B W WilliamsAmir Kalali

Abstract

This report describes the GRID-Hamilton Depression Rating Scale (GRID-HAMD), an improved version of the Hamilton Depression Rating Scale that was developed through a broad-based international consensus process. The GRID-HAMD separates the frequency of the symptom from its intensity for most items, refines several problematic anchors, and integrates both a structured interview guide and consensus-derived conventions for all items. Usability was established in a small three-site sample of convenience, evaluating 29 outpatients, with most evaluators finding the scale easy to use. Test-retest (4-week) and interrater reliability were established in 34 adult outpatients with major depressive disorder, as part of an ongoing clinical trial. In a separate study, interrater reliability was found to be superior to the Guy version of the HAMD, and as good as the Structured Interview Guide for the Hamilton Depression Rating Scale (SIGH-D), across 30 interview pairs. Finally, using the SIGH-D as the criterion standard, the GRID-HAMD demonstrated high concurrent validity. Overall, these data suggest that the GRID-HAMD is an improvement over the original Guy version as well as the SIGH-D in its incorporation of innovative features and preserva...Continue Reading

References

Jun 1, 1990·Journal of Affective Disorders·A J GelenbergG S Mok
Aug 1, 1988·Archives of General Psychiatry·J B Williams
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Jul 1, 1993·Journal of Psychiatric Research·R D GibbonsD J Kupfer
Mar 4, 2000·Journal of Psychiatric Research·D FariesW Z Potter
Feb 7, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·P J MobergV Markvart
Feb 5, 2002·European Archives of Psychiatry and Clinical Neuroscience·J B Williams
May 15, 2002·Journal of Clinical Psychopharmacology·Matthias J Müller, Armin Szegedi
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Dec 1, 2004·The American Journal of Psychiatry·R Michael BagbyMargarita B Marshall
Jan 12, 2005·Journal of Clinical Psychopharmacology·Kenneth A KobakRise Futterer
Mar 3, 2005·The American Journal of Psychiatry·Kenneth A KobakJoshua D Lipsitz

❮ Previous
Next ❯

Citations

Mar 20, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Barbara K BennettDavid Goldstein
Feb 3, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H H StassenD Hell
Feb 7, 2012·Aging & Mental Health·Kathryn MossAndrew Presnell
Apr 3, 2012·Journal of Geriatric Psychiatry and Neurology·Ariel GildengersMartha Sajatovic
Jan 29, 2013·BMC Psychiatry·Alastair J FlintUNKNOWN STOP-PD II Study Group
Nov 29, 2011·PLoS Currents·Anthony L VaccarinoKen Evans
Sep 20, 2011·PLoS Currents·Anthony L VaccarinoKen Evans
Aug 26, 2014·Comprehensive Psychiatry·Julia Krabbe, Thomas Forkmann
Dec 6, 2011·Contemporary Clinical Trials·Tyson H HolmesClete A Kushida
Feb 9, 2011·Journal of Psychiatric Research·Daniel M BlumbergerBarnett S Meyers
May 22, 2010·Journal of Psychosomatic Research·Toshi A Furukawa
Oct 27, 2015·Journal of Affective Disorders·Søren D ØstergaardBarnett S Meyers
Aug 19, 2014·Nordic Journal of Psychiatry·Maria Faurholt-JepsenLars Vedel Kessing
Dec 24, 2010·Bipolar Disorders·Ariel G GildengersUNKNOWN GERI-BD Study Group
Jul 2, 2011·Depression and Anxiety·Meredith Gunlicks-Stoessel, Laura Mufson
Jul 23, 2013·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Erita IstrianaArnt Schellekens
Jun 27, 2013·Acta Psychiatrica Scandinavica·S D ØstergaardUNKNOWN STOP-PD Study Group
Apr 3, 2016·Acta Psychiatrica Scandinavica·J NilssonP Gallagher
Dec 23, 2014·International Journal of Mental Health Systems·Yoshiyo OguchiMasaru Mimura
Jul 3, 2013·Journal of Affective Disorders·Gretchen J DiefenbachJohn W Goethe
Feb 2, 2015·Journal of Affective Disorders·Isabella HelmreichAndré Tadić
Apr 23, 2011·Journal of Psychiatric Research·Beth PangalloCeline Goldberger
Nov 21, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Anke PostJeffrey M Witkin
May 20, 2016·Psychological Medicine·A FinkelmeyerR H McAllister-Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.